UY35801A - Compuesto heterocíclico - Google Patents
Compuesto heterocíclicoInfo
- Publication number
- UY35801A UY35801A UY0001035801A UY35801A UY35801A UY 35801 A UY35801 A UY 35801A UY 0001035801 A UY0001035801 A UY 0001035801A UY 35801 A UY35801 A UY 35801A UY 35801 A UY35801 A UY 35801A
- Authority
- UY
- Uruguay
- Prior art keywords
- compound
- salt
- heterocyclic compound
- medicament
- sstr5
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013224093 | 2013-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY35801A true UY35801A (es) | 2015-06-30 |
Family
ID=51932560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001035801A UY35801A (es) | 2013-10-29 | 2014-10-28 | Compuesto heterocíclico |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9120777B2 (enExample) |
| EP (1) | EP3063139B1 (enExample) |
| JP (1) | JP6450755B2 (enExample) |
| AR (2) | AR098215A1 (enExample) |
| CY (1) | CY1121279T1 (enExample) |
| DK (1) | DK3063139T3 (enExample) |
| ES (1) | ES2710657T3 (enExample) |
| HR (1) | HRP20190133T1 (enExample) |
| HU (1) | HUE041792T2 (enExample) |
| LT (1) | LT3063139T (enExample) |
| PL (1) | PL3063139T3 (enExample) |
| PT (1) | PT3063139T (enExample) |
| RS (1) | RS58321B1 (enExample) |
| SI (1) | SI3063139T1 (enExample) |
| SM (1) | SMT201900101T1 (enExample) |
| TR (1) | TR201901986T4 (enExample) |
| TW (1) | TWI668214B (enExample) |
| UY (1) | UY35801A (enExample) |
| WO (1) | WO2015064083A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2816032A4 (en) * | 2012-02-13 | 2015-09-30 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| US9605000B2 (en) * | 2013-03-14 | 2017-03-28 | Takeda Pharmaceutical Company Limited | Spiro azetidine isoxazole derivatives and their use as SSTR antagonists |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| EP4077310B1 (en) * | 2019-12-19 | 2024-05-01 | Université de Strasbourg | Sigma-1 receptor ligands and uses thereof |
| CN116354961B (zh) * | 2021-12-27 | 2025-07-25 | 中国科学院上海药物研究所 | 生长抑素受体5拮抗剂及其药物组合物及用途 |
| CN120752056A (zh) | 2023-03-27 | 2025-10-03 | 思可海雅药品株式会社 | 生长激素分泌促进剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356906A (en) | 1989-10-27 | 1994-10-18 | The Du Pont Merck Pharmaceutical Company | (N-phthalimidoalkyl) piperidines useful as treatments for psychosis |
| ES2320973T3 (es) | 2000-06-12 | 2009-06-01 | EISAI R&D MANAGEMENT CO., LTD. | Compuestos de 1,2-dihidropiridina, procedimiento para su preparacion y uso de los mismos. |
| GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| CA2517888C (en) | 2003-03-14 | 2012-05-01 | Ono Pharmaceutical Co., Ltd. | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| KR20060123292A (ko) | 2003-11-10 | 2006-12-01 | 쉐링 악티엔게젤샤프트 | Ｃｃｒ-5 길항제로서 유용한 벤질에테르 아민 화합물 |
| JP2010500391A (ja) * | 2006-08-15 | 2010-01-07 | エフ．ホフマン−ラ ロシュ アーゲー | フェニル、ピリジン及びキノリン誘導体 |
| US7862825B2 (en) | 2007-02-21 | 2011-01-04 | Mladen Vranic | Method of controlling tight blood glucose by somatostatin receptor antagonists |
| US7799806B2 (en) * | 2007-04-04 | 2010-09-21 | Hoffmann-La Roche Inc. | Substituted n-benzyl piperidines as somatostatin receptor modulators |
| US20080306116A1 (en) | 2007-06-08 | 2008-12-11 | Christ Andreas D | Aryloxazole, aryloxadiazole and benzimidazole derivatives |
| TW200918062A (en) | 2007-09-12 | 2009-05-01 | Wyeth Corp | Azacyclylisoquinolinone and-isoindolinone derivatives as histamine-3 antagonists |
| AU2010245889A1 (en) | 2009-05-07 | 2011-11-03 | Merck Sharp & Dohme Corp. | Substituted spirocyclic amines useful as antidiabetic compounds |
| WO2012024183A1 (en) | 2010-08-18 | 2012-02-23 | Merck Sharp & Dohme Corp. | Spiroxazolidinone compounds |
| WO2012069917A1 (en) | 2010-11-26 | 2012-05-31 | Lupin Limited | Bicyclic gpr119 modulators |
| US9605000B2 (en) | 2013-03-14 | 2017-03-28 | Takeda Pharmaceutical Company Limited | Spiro azetidine isoxazole derivatives and their use as SSTR antagonists |
-
2014
- 2014-10-28 TW TW103137143A patent/TWI668214B/zh active
- 2014-10-28 TR TR2019/01986T patent/TR201901986T4/tr unknown
- 2014-10-28 RS RS20190190A patent/RS58321B1/sr unknown
- 2014-10-28 LT LTEP14800152.2T patent/LT3063139T/lt unknown
- 2014-10-28 EP EP14800152.2A patent/EP3063139B1/en active Active
- 2014-10-28 SI SI201431055T patent/SI3063139T1/sl unknown
- 2014-10-28 ES ES14800152T patent/ES2710657T3/es active Active
- 2014-10-28 HU HUE14800152A patent/HUE041792T2/hu unknown
- 2014-10-28 JP JP2016526960A patent/JP6450755B2/ja active Active
- 2014-10-28 WO PCT/JP2014/005438 patent/WO2015064083A1/en not_active Ceased
- 2014-10-28 AR ARP140104043A patent/AR098215A1/es active IP Right Grant
- 2014-10-28 US US14/525,593 patent/US9120777B2/en active Active
- 2014-10-28 PL PL14800152T patent/PL3063139T3/pl unknown
- 2014-10-28 UY UY0001035801A patent/UY35801A/es not_active Application Discontinuation
- 2014-10-28 PT PT14800152T patent/PT3063139T/pt unknown
- 2014-10-28 DK DK14800152.2T patent/DK3063139T3/en active
- 2014-10-28 HR HRP20190133TT patent/HRP20190133T1/hr unknown
- 2014-10-28 SM SM20190101T patent/SMT201900101T1/it unknown
-
2019
- 2019-02-14 CY CY20191100202T patent/CY1121279T1/el unknown
-
2022
- 2022-12-29 AR ARP220103645A patent/AR128158A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1121279T1 (el) | 2020-05-29 |
| WO2015064083A1 (en) | 2015-05-07 |
| SI3063139T1 (sl) | 2019-03-29 |
| PT3063139T (pt) | 2019-02-22 |
| JP2016535040A (ja) | 2016-11-10 |
| US9120777B2 (en) | 2015-09-01 |
| EP3063139A1 (en) | 2016-09-07 |
| TWI668214B (zh) | 2019-08-11 |
| AR098215A1 (es) | 2016-05-18 |
| PL3063139T3 (pl) | 2019-05-31 |
| LT3063139T (lt) | 2019-02-25 |
| TW201542539A (zh) | 2015-11-16 |
| TR201901986T4 (tr) | 2019-03-21 |
| AR128158A2 (es) | 2024-03-27 |
| RS58321B1 (sr) | 2019-03-29 |
| EP3063139B1 (en) | 2018-11-21 |
| DK3063139T3 (en) | 2019-03-11 |
| HRP20190133T1 (hr) | 2019-03-22 |
| HUE041792T2 (hu) | 2019-05-28 |
| JP6450755B2 (ja) | 2019-01-09 |
| SMT201900101T1 (it) | 2019-02-28 |
| ES2710657T3 (es) | 2019-04-26 |
| US20150119412A1 (en) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY35774A (es) | Compuesto heterocíclico | |
| DOP2016000206A (es) | Compuesto heterocíclico fusionado | |
| UY35995A (es) | Compuesto heterocíclico | |
| AR128158A2 (es) | Compuesto heterocíclico | |
| UY35589A (es) | Compuesto peptídico | |
| CL2017003404A1 (es) | Compuestos antibacterianos | |
| GT201700146A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| CR20120448A (es) | Compuesto heterocíclico | |
| CR20150205S (es) | Almohada de viaje | |
| CL2015003483A1 (es) | Composiciones que comprenden tintes fotocrómicos para el tratamiento de superficies. | |
| DK3174868T3 (da) | Forbindelser, der er aktive mod bromodomæner | |
| DOP2015000140A (es) | Compuesto heterocíclico | |
| MX2013006113A (es) | Compuestos biciclico. | |
| LT2984166T (lt) | Kompozicijos, skirtos mpsi gydymui | |
| CR20140537A (es) | Compuesto heterocíclico nitrogenado | |
| CO2017003699A2 (es) | Compuesto heterocíclico | |
| CL2016000190A1 (es) | Polipéptidos cíclicos para el tratamiento de la insuficiencia cardiaca. | |
| CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
| CU20160003A7 (es) | Pirazololpiridinaminas sustituidas | |
| BR112017013286A2 (pt) | composto de isoxazolina, e, uso de um composto de isoxazolina. | |
| CL2014002397A1 (es) | Polipeptidos para usarse en el tratamiento y/o prevención de una infección fúngica ocasionada por malassezia spp. | |
| CL2015002612A1 (es) | Oligonucletotidos antisentido para el tratamiento de células madre del cáncer. | |
| UY35650A (es) | Compuesto heterocíclico | |
| EA201691036A1 (ru) | Новое соединение для лечения тяжелой гипогликемии | |
| EA201690914A1 (ru) | Новое соединение для лечения тяжелой гипогликемии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20211215 |